Filter
214
Filtered Results: 214
Text search:
Ferreira,
J.P.
Featured
Recommendations
33
New Publications
26
Language
Document type
No document type
69
Studies & Reports
53
Guidelines
48
Manuals
23
Strategic & Response Plan
8
Resource Platforms
4
Training Material
3
Situation Updates
3
Fact sheets
3
Countries / Regions
Brazil
36
Latin America and the Carribbean
11
Mozambique
7
Western and Central Europe
7
Global
7
Russia
6
Ukraine
5
Eastern Europe
5
Kenya
4
South Africa
4
Colombia
4
Germany
3
Paraguay
3
Argentina
2
Eastern Europe and Central Asia
2
Africa
2
Tajikistan
2
Kyrgyzstan
2
Kazakhstan
2
Vietnam
2
France
2
Portugal
2
Spain
2
Sierra Leone
1
Ethiopia
1
Haiti
1
India
1
Turkey
1
Tanzania
1
China
1
Angola
1
Mexico
1
West and Central Africa
1
Middle East and North Africa
1
Venezuela
1
Italy
1
Southern Africa
1
North America
1
Uruguay
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
79
Clinical Guidelines
19
Public Health
17
Women & Child Health
7
Capacity Building
3
Key Resources
2
Toolboxes
COVID-19
62
Mental Health
25
TB
19
NCDs
18
HIV
13
NTDs
13
Zika
10
Rapid Response
8
Planetary Health
8
Disability
6
Conflict
4
Natural Hazards
4
AMR
4
Refugee
2
Caregiver
2
Ebola
1
Global Health Education
1
Pharmacy
1
Print version ISSN 1809-9823On-line version ISSN 1981-2256
Rev. bras. geriatr. gerontol. vol.19 no.2 Rio de Janeiro Mar./Apr. 2016
http://dx.doi.org/10.1590/1809-98232016019.150040
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were prepared following the WHO handbook for guideline dev...
We are IntechOpen, the world’s leading publisher of Open Access books Built by scientists, for scientists
Selection of our books indexed in the Book Citation Index in Web of ScienceTM Core Collection (BKCI)
http://dx.doi.org/10.5772/intechopen.68759
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
orientaciones provisionales, primera publicación: 24 de mayo de 2021, actualización: 21 de octubre de 2021, actualización: 15 de marzo de 2022
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
orientations provisoires, première publication le 25 janvier 2021, mise à jour le 15 juin 2021, mise à jour le 19 novembre 2021
Although Kenyans enjoy comparatively good health, the prevalence of
chronic disease is increasing and our ageing population is placing evergrowing pressures on the finite resources of our health system.
Rev Saude Publica. 2022; 56: 22.
Published online 2022 Apr 11. doi: 10.11606/s1518-8787.2022056004040
first issued 18 August 2022
This profile is part of a series of Climate Risk Country Profiles developed by the World Bank Group (WBG). The country profile
synthesizes most relevant data and information on climate change, disaster risk reduction, and adaptation actions and policies
at the country level. The country profile se...
Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.
Organización Mundial de la Salud. (2022). Recomendaciones provisionales sobre el uso de la vacuna CanSinoBIO Ad5-nCoV-S [recombinante] (Convidecia™) contra la COVID-19: orientaciones provisionales, primera publicación: 19 de mayo de 2022.
The Kenya Health Policy 2014-2030 aims at attaining the highest possible standard of health in a manner responsive to the health needs of our population. One of the major policy directions towards realizing the intentions of this policy is to halt and reverse the
rising burden of non-communicable d...
